Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01146457 · ClinicalTrials.gov registry record · NA
The Optimal Dosage of Intrathecal Morphine for Peripartum Analgesia
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT01146457 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 83 participants.
The verdict
NCT01146457, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the ideal dosage of intrathecal morphine for intra and post partum analgesia, while minimizing the side effect profile.
Interventions
- DRUG Saline
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01146457
The ClinicalTrials.gov registry entry for NCT01146457 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT01146457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01146457 about?
NCT01146457 is a clinical study titled "The Optimal Dosage of Intrathecal Morphine for Peripartum Analgesia". The purpose of this study is to determine the ideal dosage of intrathecal morphine for intra and post partum analgesia, while minimizing the side effect profile.
What is the current status of trial NCT01146457?
This trial is currently terminated. It is a NA study. The enrollment target is 83 participants. The study started on 2010-07. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01146457?
The interventions under investigation include: Saline (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT01146457?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.